Corporate
News

LR Health & Beauty SE publishes figures for the first half of 2025 and adjusts its forecast for 2025

• EUR 142.9 million in sales achieved in the first half of 2025
• EBITDA reported improved by 13.6% to EUR 13.3 million
• Newly appointed management team with CEO Jörg Körfer and Interim CFO Ante Franicevic drives further development of corporate strategy
• Planned discussions with bondholders of the 2024/2028 bond regarding a precautionary resolution on a waiver of compliance with the Leverage Covenant as at 30 September 2025 and an amendment to the bond terms
• Sales and earnings guidance for financial year 2025 adjusted 

Ahlen, 28 August 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its results for the second quarter and the first half of 2025. In the second quarter of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 68.9 million (Q2 2024: EUR 70.7 million) – a decline of 2.6%. In the first half of the year, sales amounted to EUR 142.9 million, representing a slight decrease of 0.3% compared with the prior-year figure of EUR 143.3 million. This development reflects the generally subdued consumer sentiment, particularly noticeable in Western European markets.

In addition, LR Health & Beauty SE achieved EBITDA reported of EUR 13.3 million in the first six months of 2025, representing a significant increase of 13.6% compared with the prior-year period (H1 2024: EUR 11.7 million). In the prior-year period, refinancing costs incurred in connection with the redemption of the previous bond had weighed on earnings. Normalized EBITDA increased by 6.3% to EUR 15.3 million in the first half of 2025 (H1 2024: EUR 14.4 million).

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations LR Health & Beauty SE, comments: “In the first half of 2025, we focused on further enhancing the foundations for the business success of our distributors. Our product innovations play an important role in this. Through regular product launches and the targeted expansion of our portfolio, we are opening up attractive business opportunities for our distributors in a generally challenging market environment.”

New leadership team with proven expertise

With a newly formed leadership team, LR is consistently driving the further development of its corporate strategy. As of 1 August 2025, Mr Jörg Körfer was appointed Chief Executive Officer (CEO). He brings extensive expertise in global direct sales from his many years of senior management positions at internationally operating companies, including Bofrost and Vorwerk. In addition, LR has strengthened its management team with the appointment of Mr Ante Franicevic, who serves as Interim Chief Financial Officer (CFO). Mr Franicevic contributes more than 20 years of senior management experience in finance at well-known retail and consumer brands such as Douglas, Jack Wolfskin and Metro.

Jörg Körfer, CEO of LR Health & Beauty SE, states: “As a newly formed leadership team, our clear goal is to continue LR’s success story as Europe’s leading social commerce company. Our Global Leader Convention in Berlin, marking the company’s 40th anniversary, and the Business Days in September provide an ideal opportunity to strengthen our engagement with our community members and to launch new business initiatives. Together with our distributors, we aim to make the company even stronger and more innovative, thereby ensuring sustainable success for LR in a challenging market environment.”

2024/2028 bond

Today, the Management Board of LR Health & Beauty SE resolved to initiate precautionary negotiations with the holders of the 2024/2028 bond (ISIN: NO0013149658) regarding a proposal to amend the bond terms and, if necessary, to request their consent to a waiver of the Leverage Covenant as at 30 September 2025. The background is a potential breach of the company’s obligation under Clause 13.2 of the bond terms, which requires the company to ensure that net debt in relation to EBITDA (the “Leverage Covenant”) does not exceed the threshold of 4.50:1 as at 30 September 2025. The Leverage Covenant was reduced from 4.75:1 to 4.50:1 as of 1 July 2025. Based on preliminary calculations, the Management Board currently assumes that the Leverage Covenant is unlikely to be met on the review date of 30 September 2025. This is due to EBITDA developing less favourably than expected, primarily due to increased or increasing costs in the areas of marketing and sales.

Outlook 2025

Furthermore, LR’s Management Board is adjusting the guidance for the 2025 financial year published on 25 April 2025. With regard to sales (revenue from goods sold), the Management Board now expects a stable development compared with the previous year. Previously, stable to moderately increasing sales had been forecast. EBITDA for the 2025 financial year is now expected to range between EUR 24.0 million and EUR 27.0 million – whereas the previous guidance anticipated significant EBITDA growth compared to the previous year’s figure of EUR 27.3 million. The revision of the EBITDA guidance is essentially due to increased or increasing costs in the areas of marketing and sales. This trend also continued in July, leading the Management Board to conclude that the previous guidance is unlikely to be achieved through catch-up effects or cost-saving measures.

The full report for the second quarter and the first half of 2025 will be available from 29 August 2025 on the corporate website: https://ir.lrworld.com/.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence. 

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe. 

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Contact:

PR contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
 

LR Health & Beauty welcomes Jörg Körfer as new CEO – focus remains on growth and operational excellence

Ahlen, 21 July 2025 – LR Health & Beauty SE announces that Mr Jörg Körfer has been appointed Chief Executive Officer (CEO). He will take over the responsibilities of the previous members of the Management Board, Dr Andreas Laabs and Andreas Grootz, with effect from 1 August 2025. Both gentlemen will leave the company by mutual agreement on 31 July 2025. In order to further strengthen the management team in the future, the Supervisory Board is exploring options for another complementary member of the Management Board. 

Jörg Körfer has extensive expertise in global direct sales from his many years of management experience with international companies. Among other things, he spent 14 years at Vorwerk (CEO Kobold and CEO Thermomix) and served as Chairman of the Advisory Board at Bofrost for six years, as well as acting as CEO in an advisory capacity. He will now bring this experience to LR and continue to exploit the full potential of Europe’s leading social commerce platform in line with the strategy that has been pursued.

The Supervisory Board would like to express its sincere thanks to the two departing members of the Management Board for their trust and dedication. Under Dr Laabs’ leadership in particular, LR has developed excellently over the past eleven years and is ideally positioned to enter its next phase of growth. Since joining LR in 2014, Dr Laabs has played a key role in shaping the company and successfully transformed LR from a traditional direct sales model into a globally active social commerce company. The key milestones of his tenure include the digitalisation of the business model, several of LR’s most successful product launches, and infrastructure projects such as the insourcing of Aloe Vera Drinking Gels in 2018 and the opening of the IT hub in Athens, all of which have contributed significantly to LR’s current position.

Andreas Grootz is leaving the company after fourteen years. He established capital market-compatible governance structures at LR and drove forward the opening of new markets. 

The Supervisory Board is confident that Mr Körfer is the right successor to LR to continue the success story started by Dr Laabs and his team.


Contact:

Public Relations:
LR Global Holding
Almut Kellermeyer     
Head of PR / Public Affairs    
Kruppstraße 55    
59227 Ahlen    
Tel.: +49(0)2382 7813-106
Email: a.kellermeyer@LRworld.com
https://ir.lrworld.com/


Investor Relations:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Tel.: +49(0)611 – 205855-23
Fax: +49(0)611 – 205855-66
Email: burbach@cometis.de

LR Health & Beauty SE grows profitably in the first quarter 2025

• Sales increased by 2.0% to EUR 74.0 million in the first quarter
• EBITDA reported significantly improved by 20.5% to EUR 7.4 million
• Digitalisation and process optimisation in logistics & IT increase efficiency
• Forecast for the financial year 2025 confirmed

Ahlen, 26 May 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its figures for the first quarter of 2025. In the first three months of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 74.0 million (Q1 2024: EUR 72.6 million). Despite the generally subdued consumer sentiment in Europe, the company was able to increase sales by 2.0% compared to the first quarter of the previous year. 

Furthermore, EBITDA reported amounted to EUR 7.4 million (Q1 2024: EUR 6.1 million) in the first quarter of 2025, which corresponds to a significant increase of 20.5% compared to the same period of the previous year. On the one hand, both the sales growth achieved, and overall stable cost structures had a positive effect. On the other hand, one-off extraordinary effects due to the premature refinancing of the old bond burdened the EBITDA reported in the previous year’s quarter. In the first quarter of 2025, normalized EBITDA rose by 4.9% to EUR 8.2 million compared to the corresponding value of the previous year of EUR 7.8 million. 

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of LR Health & Beauty SE, comments: “The good start to the 2025 financial year has confirmed that we have set the course for profitable growth with our strategic growth initiatives such as the realignment of the career plan and the continuous expansion of our product range.
With the ongoing digitalisation of our business processes and the launch of our new logistics centre, we are also successfully working towards making our business even more efficient and profitable.”

Successful digitalisation of business processes 

The logistics centre at the Ahlen site has been fully commissioned and now also enables direct deliveries to LR sales partners and customers in various markets. At the heart of the logistics centre is a state-of-the-art storage system that increases efficiency and improves scaling possibilities. The further digitalisation of business processes is reflected not only in the optimised logistics, but also in the expansion of the company's own IT infrastructure. The opening of the IT hub in Athens is helping to ensure that business applications can increasingly be developed and operated internally.

Dr. Andreas Laabs, CEO of LR Health & Beauty SE summarises: “Our partner community has started the new year with a lot of energy, and we have seen a great response to our Business Days. With the launch of the new LR Aloe Via Magic Power Duo skincare range, we have furthermore underpinned our high quality standards in the field of skincare. We aim to utilise the tailwind from the first quarter to continue our growth trajectory. On top of seasonal sales initiatives such as ‘Crazy Summer’, we are also planning a major new product launch for the second half of the year, which will give our partner community further impetus for sales."

Outlook 2025

LR Health & Beauty still expects to be able to consistently utilize the growth opportunities in the Health & Beauty segments despite the tense market situation in large parts of Europe. Based on conservative assumptions, the company continues to expect stable to moderately rising sales (revenue from goods sold) and significantly higher EBITDA for the 2025 financial year compared to the previous year.

The full report for the first quarter is available from today on the company website at https://ir.lrworld.com/. 

In addition, the Sustainability Report 2024 is now available for download at https://ir.lrworld.com/en/sustainability/.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com  
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE continues growth trajectory in the 2024 financial year

• Sales increased to EUR 289.2 million
• EBITDA reported at EUR 27.3 million, burdened by one-off extraordinary effects
• Career plan realignment leads to significant boost in new sales careers
• Successful launch of new LR Aloe Via Magic Power Duo skincare range contributes to positive business outlook in 2025
• 2025 forecast: significant increase in EBITDA with stable to moderate sales growth

Ahlen, 25 April 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final audited financial results for 2024. With this, the Group confirms the preliminary figures for the 2024 financial year announced on 28 February 2025, according to which LR Health & Beauty SE achieved sales (revenue from goods sold) of EUR 289.2 million (2023: EUR 276.5 million), representing a year-on-year increase in sales of 4.6%. This increase was significantly driven by the realignment of the career plan, on the one hand, and the successful launches of the colour cosmetics line LR ZEITGARD Signature, and the intestinal metabolism treatment LR HEALTH MISSION, on the other. The LR Group therefore achieved its sales forecast for 2024, which it had raised in November to a range of EUR 288 to 292 million.

Furthermore, LR Health & Beauty SE achieved an EBITDA reported of EUR 27.3 million in the 2024 financial year, compared to EUR 31.4 million in the previous year. This was in line with the forecast for EBITDA reported, which had been adjusted in November to a range of EUR 26 to 29 million. In the reporting period, earnings development was particularly impacted by one-off, extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024. Normalized EBITDA amounted to EUR 32.6 million in 2024 (2023: EUR 35.4 million).

Dr Andreas Laabs, Chief Executive Officer (CEO) of LR Health & Beauty SE, elaborates on the Group’s strategic initiatives: “In 2024, we consistently executed our strategy and took a major step toward long-term corporate success with the realignment of our career plan. This year, we are again seeing a strong increase in the number of new distributors who are using our onboarding programmes to launch their careers. By continuing to digitalise our business processes, we are empowering our partner community to grow their careers successfully. At the same time, we are expanding our digital offering – whether through training, information, or sales initiatives.” 

Innovative product launches drive new growth opportunities

In 2025, the LR Group will continue to focus on expanding and optimising its product portfolio. The new LR Aloe Via Magic Power Duo skincare range was successfully launched in April. This innovative skincare range features an even more powerful fermented aloe vera extract.

Valdemaras Gordinskis, the LR Group’s Vice President Global Controlling and Investor Relations, comments: “Processing aloe vera has always been one of LR’s core competencies. Now, with the unique combination of pure aloe vera leaf gel and fermented aloe vera, we have taken skincare a step further. With the patented Aloe Via Magic Power Duo product solution, we are setting new standards in skincare and expanding our range of health and beauty products. For LR, product innovation is an important pillar on the path to sustained profitable growth.”

Positive outlook for 2025

LR Health & Beauty SE is well positioned to take advantage of the attractive growth opportunities in the health & beauty sectors. Against a backdrop of high uncertainty in the market environment and continued consumer reticence, LR expects stable to moderately rising sales (revenue from goods sold) in the 2025 financial year, based on conservative assumptions. Furthermore, given the expected sales development, operational improvements and the absence of extraordinary effects compared to the previous year, the Group is expected to achieve a significant year-on-year increase in EBITDA. 

The full 2024 Annual Report is available from today on the company website at https://ir.lrworld.com/. At the end of May 2025, LR will also publish the 2024 Sustainability Report and make it available for download here.

LR Group
Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com  
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024
8.0% increase in sales in Q4 2024 to EUR 76.5 million, confirming growth trend 
Full-year sales at EUR 289.2 million, up 4.6% y-o-y
EBITDA reported of EUR 8.3 million in Q4 2024 and EUR 27.3 million in FY 2024 due to one-off charges 
Realignment of career plan and successful product launches such as LR ZEITGARD Signature provide positive momentum in 2024 and beyond

Ahlen, 28 February 2025 - LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today publishes its figures for the fourth quarter of 2024 as well as preliminary sales and earnings figures for the full year 2024.

LR Health & Beauty SE closed the 2024 financial year with significant sales growth in the fourth quarter, confirming the growth trend of the third quarter. In the fourth quarter of 2024, LR achieved sales (revenue from goods sold) of EUR 76.5 million (Q4 2023: EUR 70.9 million), representing growth of 8.0%. For the full year 2024, LR Health & Beauty SE reports sales of EUR 289.2 million, compared to EUR 276.5 million in the previous year. This corresponds to an increase of 4.6% and is in line with the LR Group’s 2024 sales forecast of EUR 288 to 292 million, which had been raised in November.

“LR Group’s strong growth is confirmation that we are on the right track with our strategy. The positive performance in the final quarter of 2024 is primarily the result of the realignment of the career plan and the successful market launch of further product innovations. We’re constantly working to create the best possible conditions for the business success of our partners, who participated with great enthusiasm in a wide range of kick-off events at the beginning of the year. With LR ZEITGARD Signature, we have perfectly complemented our portfolio in the area of colour cosmetics. We are confident that this solid foundation will enable us to continue our growth trajectory in the year of LR’s 40th anniversary,” says Dr. Andreas Laabs, CEO of LR Health & Beauty SE.

In the fourth quarter of 2024, LR Health & Beauty SE generated EBITDA reported of EUR 8.3 million (Q4 2023: EUR 9.0 million). On a preliminary basis, EBITDA reported for the full year 2024 reached EUR 27.3 million, compared to EUR 31.4 million in 2023 and was therefore in line with the forecast for EBITDA reported adjusted in November to EUR 26 to 29 million. In particular, one-off extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024 had a negative impact on the earnings development in the financial year. Normalized EBITDA decreased to EUR 9.5 million in the fourth quarter of 2024, compared to EUR 10.2 million in the fourth quarter of the previous year. In the full year 2024, normalized EBITDA reached EUR 32.6 million on a preliminary basis (2023: EUR 35.4 million).

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations at LR Health & Beauty SE, comments: “In 2025, we will continue to focus on implementing further strategic measures. For example, we are stepping up the development of new product innovations in order to expand our range of high-quality nutritional supplements and cosmetic products. We will also focus on increasing the efficiency and profitability of the LR Group through operational improvements in production and logistics as well as the further digitalization of our sales activities.”

The report for the fourth quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/. The final, audited figures for the 2024 financial year will be published on the company website at the end of April 2025, together with the annual report. 

* As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the fourth quarter and the full year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH.
 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm

Ahlen, 26 February 2025 – On 4 March 2024, LR Health & Beauty SE (“LR SE”) issued senior secured floating rate bonds (2024/2028) in an amount of EUR 130,000,000 (the “Bonds”). Under the terms and conditions for the Bonds, LR SE has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For the purpose of the admission to trading, LR SE has prepared a listing prospectus which has been approved by the Swedish Financial Supervisory Authority today. LR SE will submit an application for admission to trading of the Bonds and the first trading day on Nasdaq Stockholm is expected to be on or about 28 February 2025. 

The prospectus will be available at LR Group’s website, ir.lrworld.com/en/bond/ and the Swedish Financial Supervisory Authority’s website www.fi.se. 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts:

PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE further increases growth trend in the third quarter 

• Sales significantly increased by 7.2% to EUR 69.4 million in the third quarter of 2024
• In Q3 2024 EBITDA reported rose to EUR 7.3 million and normalized EBITDA increased to EUR 8.7 million
• Successful market launch of LR ZEITGARD Signature and realignment of the career plan increased the number of new distributors and led to higher sales
• Adjusted guidance for 2024: Sales range of EUR 288 million to EUR 292 million, EBITDA reported in the corridor of EUR 26 million to EUR 29 million

Ahlen, 26 November 2024 – LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today published its figures for the third quarter of 2024 and the first nine months of 2024. Despite the challenging market environment, LR Health & Beauty SE increased sales (revenue from goods sold) by 7.2% to EUR 69.4 million in the third quarter of 2024 (Q3 2023: EUR 64.7 million). This resulted in sales for the first nine months of 2024 of EUR 212.7 million compared to EUR 205.6 million in the previous year, an increase of 3.4%. The recent market launch of the cosmetic product range LR ZEITGARD Signature and the realignment of the career plan for distributors made a major contribution to sales growth. 

On top of that, EBITDA reported increased in the third quarter of 2024 to EUR 7.3 million compared to EUR 7.1 million in the third quarter of the previous year. As a result, EBITDA reported in the first nine months of 2024 totaled EUR 19.0 million compared to EUR 22.4 million in the prior year period. Normalized EBITDA increased sharply from EUR 7.7 million in the third quarter of the previous year to EUR 8.7 million in the third quarter of 2024, resulting in a figure for the first nine months of EUR 23.1 million (9M 2023: EUR 25.2 million).  

Dr. Andreas Laabs, CEO of LR Health & Beauty SE, comments: "With the introduction of the new LR ZEITGARD Signature product category, we have achieved one of the most successful product launches in LR's history and seamlessly continued our journey of successful market launches of the recent past. In addition, we have further improved the attractiveness of our business model for distributors by realigning our career plan. We are currently experiencing a decent influx of new distributors and a significant increase in the number of successful careers. Accordingly, we are looking forward to continuing to grow significantly in 2024 and believe we are ideally positioned for an even more successful 2025.“

Based on the business results for the first nine months of 2024 and the realignment of the career plan for distributors in the third quarter of 2024, LR Health & Beauty SE is adjusting its forecast for sales and EBITDA reported for the full year 2024. LR Health & Beauty SE is increasing the sales guidance for the 2024 financial year and now expects a sales corridor of EUR 288 million to EUR 292 million. Management originally assumed that sales (revenue from goods sold) would be at the previous year's level (2023: EUR 276.5 million). The company is also adjusting its earnings expectations for 2024 and revising its forecast for EBITDA reported to be in the range of EUR 26 million to EUR 29 million. Originally, management expected a slightly lower to stable EBITDA figure year-on-year (2023: EUR 31.4 million). The underlying reason is that the realignment of the career plan for distributors in the third and fourth quarters of 2024 will lead to a significant increase in distributors, which will have a positive impact on sales development. At the same time, the result is burdened by refinancing costs incurred and, above all, by one-off, extraordinary effects in the low single-digit million euro range due to changes to the distributors' career plan.   

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of LR Health & Beauty SE, explains: “With the realignment of the career plan, we have set an important course for sustainable profitable growth. This is likely to result in one-off, extraordinary effects in the fourth quarter, which will have a negative impact on earnings. However, in the financial year 2025 this will yield positive effects on sales and profitability.“ 

With the new logistics centre at the Ahlen site, which was put into operation in October 2024, LR sets the course for future growth. A state-of-the-art warehouse system will ensure efficiency gains and improve scaling possibilities.

The full report for the first nine months of the financial year 2024 is available online from today on the company website at https://ir.lrworld.com/. 

* As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the third quarter and the first nine months of financial year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH. 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE confirms growth trend in the second quarter of 2024

• Sales increased to EUR 143.3 million in the first half of 2024
• Normalized EBITDA of EUR 14.4 million
• Rising demand for subscription concepts like the successful LR Health Mission 
• Growth prospects strengthened by innovative product range and planned launch of a new product segment in September

Ahlen, 30 August 2024 – LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality health and beauty products, today published its figures for the second quarter of 2024 and the first half of 2024. In the second quarter of financial year 2024, LR Health & Beauty SE managed to increase sales (revenue from goods sold) by 2.6% to EUR 70.7 million (Q2 2023*: EUR 68.9 million). In the first half of the year, LR Health & Beauty SE thus generated sales of EUR 143.3 million (H1 2023*: EUR 140.9 million). New product launches, such as the LR Health Mission and the LR Body Mission, contributed significantly to the positive sales performance during the period.

Furthermore, LR Health & Beauty SE generated a normalized EBITDA of EUR 14.4 million in the first six months of financial year 2024, compared to EUR 17.5 million in the same period of the previous year*. The earnings performance was impacted by factors such as refinancing costs related to the early redemption of the old bond of LR Global Holding GmbH and the issuance of a New Bond by LR Health & Beauty SE, as well as negative currency effects. EBITDA reported amounted to EUR 11.7 million in the first half of 2024, compared to EUR 15.4 million in the same period of the previous year*.

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “The LR Group’s business development has been very robust in the first half of the year and we have managed to achieve growth despite general consumer reticence in all of our regions. We are also pleased to see that our subscription concepts attract increasing interest. This is evidenced, for example, by the strong demand for the LR Health Mission with its novel product range. With this subscription, we offer those interested a 6 months treatment for the intestinal, liver and cellular metabolism, providing a comprehensive solution for personal health support.”

Future growth driven by digitization and IT expansion

LR Health & Beauty SE’s CEO Dr Andreas Laabs explains: “We will continue to consistently execute our corporate strategy in the second half of the year. In particular, we will drive our initiatives to optimize our marketing activities and our partner programs. At the same time, expanding our innovative product range remains high on our agenda. A new product segment is planned to be launched at the LR Business Day event with our partners in September. We are confident that the new products will be an ideal addition to our range and will open up new and attractive opportunities for our partners.”

Another important pillar for future growth is the continued digitization and expansion of the IT landscape. For this purpose, the LR Group will establish a new IT hub in Athens in order to provide high-quality IT services in-house and to develop and operate suitable business applications for social commerce.

LR Health & Beauty SE expects that it will continue to be in a position to capitalize on growth opportunities in the health and beauty markets. At the same time, the LR Group continues to face a challenging market environment and ongoing consumer reticence. Based on conservative assumptions, LR continues to expect sales at the previous year’s level and an only slightly lower or stable EBITDA for the 2024 financial year.

The full report for the first half of financial year 2024 is available online from today on the company website at https://ir.lrworld.com/. 
  

*As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the second quarter and the first half of financial year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE delivers good start into the 2024 financial year

• Sales of EUR 72.6 million in the first quarter of 2024
• Normalised EBITDA of EUR 7.8 million
• Focus on further expansion of innovative product range
• Digital initiatives progressing successfully

Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social selling company in the area of high-quality health and beauty products, today published its figures for the first quarter of 2024, according to which LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 72.6 million (2022*: EUR 72.0 million). Despite unfavourable currency effects, the company thus achieved a slight increase in sales of around 0.8% compared to the first quarter of the previous year. 

In terms of earnings, LR Health & Beauty SE generated normalised EBITDA of EUR 7.8 million in the first three months of 2024, compared to EUR 8.7 million in the same period of the previous year. Earnings were impacted by the refinancing costs associated with the early redemption of the old bond of LR Global Holding GmbH and the issue of the new bond of LR Health & Beauty SE. EBITDA reported in the first quarter of 2024 was EUR 6.1 million, compared to EUR 7.8 million in the first quarter of 2023.

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “All in all, LR has made a good start into the year 2024 and has achieved a sound performance in the important markets of Western and Eastern Europe. New product launches from previous periods, in particular the innovative BODY MISSION, made a significant contribution to growth in the first quarter. The success of our latest product launches once again validates our strategy.”

Integrating AI to streamline social selling processes

Dr Andreas Laabs, CEO of LR Health & Beauty SE, explains: “In 2024, we will continue to focus on the further digitalisation of our company and the use of innovative technologies to further optimise our business processes. We also strive to provide our partners with the best possible sales support through new product innovations. Our pipeline for this year includes both new products and seasonal sales promotions such as ‘Crazy Summer’. We’re also preparing the launch of a new product segment for the autumn of 2024, which will perfectly complement our product offering.”

LR is placing great focus on the further digitalisation of its business processes. For example, through the Group’s digital platform LR neo, partners can now access a wide range of information relevant to their sales activities. The company has also developed its own chatbot: “LR-Vera” is designed to support efficient customer service. The chatbot enables customer service centre staff to access a centralised knowledge pool that facilitates quick and comprehensive answers.

Outlook 2024

LR Health & Beauty SE expects that it will continue to capitalise on the growth opportunities in the Health & Beauty segments and sees this confirmed by a further increase in momentum in the second quarter of the year. Based on conservative assumptions, LR continues to expect sales at the previous year’s level and an only slightly lower or stable EBITDA for the 2024 financial year.

The full report for the first quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/ 

*As issuer of the New Bond 2024/2028, LR Health & Beauty SE discloses the figures for the first quarter of 2024 and for the first quarter of the previous year 2023. The previous year’s figures for 2023 may differ from the figures for 2023 disclosed previously by LR Global Holding GmbH.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication 
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de

LR Health & Beauty SE reports a successful 2023 financial year and expands its innovative product range

• Sales increase to EUR 276.5 million; EBITDA reported reaches EUR 31.4 million
• Digitalisation and sales activities promote partners’ career development
• Expansion of innovative product range provides for positive business outlook

Ahlen, 30 April 2024 – LR Health & Beauty SE, Europe’s leading digital social selling company in the area of high-quality health and beauty products, today announced its final figures for the 2023 financial year. Accordingly, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 276.5 million (2022*: EUR 269.4 million). This meant that the company achieved a slight increase in sales of around 3% year-over-year despite negative currency effects. 

Furthermore, LR Health & Beauty SE achieved a normalized EBITDA of EUR 35.4 million in the 2023 financial year, compared to EUR 36.0 million in the previous year. EBITDA reported increased to EUR 31.4 million in 2023 compared to the previous year’s figure of EUR 31.1 million.

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “2023 was a very strong year for LR. We were able to drive forward our strategic initiatives, and many partners saw successful career developments. With BODY MISSION and Mind Master Gold, we managed to achieve two of the three best product launches in the history of our company. Especially Mind Master Gold, a vegan health product, which is available for subscription, has been very well received by the community and has given our sales an extra boost.”

Expanding the innovative product range  

In the current financial year, LR continues to consistently implement its corporate strategy. This includes a further digitalisation of business processes. With the LR neo sales platform, the company has established a centralised platform for partners to make their business processes more efficient and better tailored to their needs. Since April 2024, the information available on this platform has been further expanded.  

As Dr. Andreas Laabs, CEO of LR Health & Beauty SE, explains, the company is also focusing on expanding its innovative product portfolio: “We have started well into the 2024 financial year and strive to give additional impulses to our partners’ activities by launching even more innovative products. With our LR Health Mission, we offer a 6 month treatment for the intestinal, liver and cellular metabolism, providing a holistic solution for health support. In April 2024, we have launched two additional products that ideally complement this cure.”

Outlook 2024

LR Health & Beauty SE is generally well-positioned to address the attractive growth opportunities in the health & beauty market. Given the high level of uncertainty in the market environment, LR expects sales to remain at last year’s level in FY 2024 despite the good start to the year, and a slightly lower or stable EBITDA, based on conservative assumptions.

The complete 2023 Annual Report is available online from today on the company website at https://ir.lrworld.com/. Please also refer to our website for the Sustainability Report 2023, which provides information on our current initiatives such as the commissioning of a new photovoltaic system at the Ahlen site.

*As issuer of the New Bond 2024/2028, LR Health & Beauty SE discloses the final figures for the 2023 financial year and for the previous year 2022. The previous year’s figures for 2022 may differ from the figures for 2022 disclosed previously by LR Global Holding GmbH.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE 
Almut Kellermeyer  
Head of Corporate Communication 
Kruppstraße 55 
59227 Ahlen 
Phone: +49(0)2382 7813-106
E-Mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Gebäude D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-Mail: burbach@cometis.de